Utah Medical Products UTMD Finite-Lived Intangible Assets - Expected Amortization Expense (Year One)
Finite-Lived Intangible Assets - Expected Amortization Expense (Year One) at other companies
Other financials
Where this comes from
Reported directly by Utah Medical Products in its filing.
Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour.
The official record: Utah Medical Products’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Utah Medical Products's finite-lived intangible assets - expected amortization expense (year one).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Utah Medical Products's finite-lived intangible assets - expected amortization expense (year one)?
- Utah Medical Products (UTMD) reported finite-lived intangible assets - expected amortization expense (year one) of $9K in Q4 2025.
- How has Utah Medical Products's finite-lived intangible assets - expected amortization expense (year one) changed year-over-year?
- Utah Medical Products's finite-lived intangible assets - expected amortization expense (year one) decreased by 18.2% year-over-year, from $11K to $9K.
- What is the long-term trend for Utah Medical Products's finite-lived intangible assets - expected amortization expense (year one)?
- Over 5 years (2020 to 2025), Utah Medical Products's finite-lived intangible assets - expected amortization expense (year one) has grown at a -66.5% compound annual growth rate (CAGR), from $2.12M to $9K.
- What does finite-lived intangible assets - expected amortization expense (year one) mean?
- This metric forecasts the amortization expense expected to be recognized in the upcoming fiscal year for intangible assets with finite useful lives. It provides visibility into the non-cash earnings impact of previously acquired intangible assets. Analysts use this to refine future earnings projections and cash flow models.